Medical Science News

RSS

UCSF launches global study tracking real-world psychedelic experiences

Most psychedelic experiences don't happen in research labs. To better understand their effects, UC San Francisco scientists are going where the experiences are and launching a global study to track what psychedelics do to people's brains, bodies and well-being.

10 Nov 2026

NIH grant supports research into PFAS effects on mosquitoes

Kennesaw State University researcher Andrew Haddow has received a three-year grant from the National Institutes of Health (NIH) worth $517,956 to study the effects of per- and polyfluoroalkyl substances (PFAS), or "forever chemicals," on mosquitoes.

10 Nov 2026

New biomarker may extend detection window for date-rape drug GHB

Gamma-hydroxybutyrate (GHB) can be consumed as a recreational drug or administered secretly to knock victims out.

10 Nov 2026

Repeat thieves show impaired ability to learn from consequences

Theft is almost universally considered an exploitative behavior. The conventional view underlying judicial systems is that the act of taking resources from others without offering compensation stems from moral and personal failings.

10 Nov 2026

Could eating more mushrooms help protect your brain as you age?

A review of existing research suggests that ergothioneine, a natural antioxidant found primarily in mushrooms, may protect brain cells against oxidative stress, inflammation, and damage associated with Alzheimer's and Parkinson's diseases. Although laboratory and animal studies show promising neuroprotective effects, human evidence remains limited, and larger clinical trials are needed to determine whether supplementation can prevent or slow neurodegeneration.

10 Nov 2026

Protein marker detects early Huntington's disease before brain damage

Before motor or cognitive impairments appear and before brain volume loss becomes evident, some individuals carrying the genetic mutation that causes Huntington's disease already show signs of neuronal injury.

10 Nov 2026

Regular coffee consumption alters gut bacteria and digestive physiology

If you drink coffee regularly, it appears to alter not only your gut bacteria but also the physiology of the gut itself. That is the conclusion of a study from the University of Copenhagen, which may help point the way towards better treatments for constipation.

10 Nov 2026

Why are some patients lying to their doctors to get antibiotics?

A study finds 28% of adults misrepresent symptoms to secure antibiotics, highlighting risks for antimicrobial resistance and the need for better communication.

10 Nov 2026

Your Instagram photos may reveal more about loneliness than you think

Researchers analyzing Instagram data from 415 US college students found that photographs, language, and online activity provided moderately useful indicators of subjective loneliness but were less informative about social isolation. Social loneliness was associated with lower interpersonal engagement, while emotional loneliness was linked to negative language, sad or angry facial expressions in profile photographs, and late-night posting.

9 Nov 2026

Drinking 2–3 cups of coffee a day? A study of 495,000 adults links it to lower AF risk

In a prospective study of 495,269 UK Biobank participants followed for approximately 13 years, researchers found that coffee consumption was associated with a 7% to 11% lower risk of atrial fibrillation (AF), with the strongest association observed at 2–3 cups daily. Tea consumption showed a more modest and less consistent association, with the authors reporting a 5% lower AF risk at 2–3 cups daily, although the observational findings cannot establish causation.

9 Nov 2026

BioUK acquires certain key assets of SEHTA to strengthen support for life science SMEs across the UK

BioUK Ltd., the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced that it has acquired certain key assets of SEHTA (Science and Engineering Health Technologies Alliance) through an asset purchase agreement.

From BioUK 9 Nov 2026

Late night eating and sleep habits damage gut health, increase metabolic disease risk

A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health, and metabolic disease, offering new insights into why some individuals with obesity may face risk of inflammation and related health problems.

9 Nov 2026

DNA methylation patterns predict treatment response in MDS patients

DNA methylation patterns present at diagnosis could help predict which patients with myelodysplastic syndromes (MDS) will respond to azacitidine.

9 Nov 2026

Blocking complement factor B halts pancreatic cancer growth

Researchers have identified a promising new target in the treatment of pancreatic cancer. A new study in The American Journal of Pathology, published by Elsevier, demonstrates that blocking complement factor B (CFB), a pivotal enzyme in the alternative complement pathway, halts cancer growth and alters the tumor microenvironment.

9 Nov 2026

Breast milk contains urea. Researchers think it may play an unexpected role

Researchers found that urea concentrations in breast milk change during lactation, with evidence suggesting that the mammary gland regulates its transport independently of measured maternal dietary and blood urea levels. Laboratory experiments showed that different urea concentrations favored the growth of different bacterial strains, suggesting a possible role in shaping the infant gut microbiome and raising questions about the composition of infant formula.

9 Nov 2026

Could a single brain scan reveal how quickly your body is aging?

Researchers examined whether DunedinPACNI, an MRI-derived measure of brain aging, was associated with blood-based indicators of biological aging in 746 adults across two independent midlife cohorts. Faster DunedinPACNI was associated with higher levels of multisystem biological aging in both cohorts and greater changes in aging-related blood biomarkers over 7–15 years in a longitudinal subgroup of 224 participants.

9 Nov 2026

Study reveals how astrocytes regulate brain blood flow and activity

What happens in our brains when we experience sensory stimulation? During everyday activities such as jogging, reading, or listening to music, sensory inputs activate neurons in specific brain regions.

9 Nov 2026

Could a daily supplement keep blood vessels healthier as we age?

The study highlights a multi-compound nutritional supplement's potential to improve blood vessel function and lower blood pressure, aiding vascular health.

9 Nov 2026

New mRNA therapy reawakens heart muscle cells to repair damage

Scientists have developed a treatment that 'reawakens' heart muscle cells so they start to divide and help repair damaged muscle.

9 Nov 2026

Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight's Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum's PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum's lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

From Qureight 9 Nov 2026